🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a a phase 1, open label study to assess the safety and efficacy of ...
Status
Unknown
Location
Multiple Locations
Start Date
2022-10-15
Trial ID
NCT05576181
Treatments Being Tested
The primary objective is to assess the safety of the addition of venetoclax...
Status
Not Yet Recruiting
Location
Massachusetts General Hospital
Start Date
2026-07
Trial ID
NCT07358195
This is a Phase 1, open-label, single center study of short-course oral ven...
Status
Unknown
Location
Melbourne Health
Start Date
2022-06-08
Trial ID
NCT05005299
Treatments Being Tested
The purpose of the phase 1 portion (dose escalation) of the study was to es...
Status
Terminated
Location
St. Jude Children's Research Hospital
Start Date
2020-09-04
Trial ID
NCT04240002
Treatments Being Tested
The primary objective of the study is to determine whether quizartinib mono...
Status
Completed
Location
City of Hope National Medical Center
Start Date
2014-05
Trial ID
NCT02039726
Treatments Being Tested
The participants are being asked to take part in this clinical trial becaus...
Status
Terminated
Location
St. Jude Children's Research Hospital
Start Date
2023-03-14
Trial ID
NCT05579769
A randomized，multicenter, open-label Phase III, clinical study is conducted...
Status
Recruiting
Location
the First Affiliated Hospital,College of Medicine,Zhejiang University
Start Date
2023-03-03
Trial ID
NCT05586074
Treatments Being Tested
The purpose of this study is to assess the antitumor effect and safety of f...
Status
Completed
Location
Multiple Locations
Start Date
2005-12
Trial ID
NCT00311129
Treatments Being Tested
This is a randomized, multi-center, double-blind, placebo-controlled study ...
Status
Completed
Location
City of Hope National Medical Center
Start Date
2018-08-16
Trial ID
NCT03250338
Treatments Being Tested
The purpose of this study was to determine the clinical benefit of ASP2215 ...
Status
Completed
Location
Site US10011
Start Date
2015-10-20
Trial ID
NCT02421939